Currently holds a position at Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Syndax Pharmaceuticals Inc | March 29, 2017 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-10-07 | 2022-10-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
9,117
-22.2%
25.90236,139 USD |
9,117 -22.2% | 25.90 | 236,139 USD | |
2022-10-07 | 2022-10-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
20,782
-39.4%
25.90538,273 USD |
20,782 -39.4% | 25.90 | 538,273 USD | |
2022-10-04 | 2022-10-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
223
-0.7%
25.005,575 USD |
223 -0.7% | 25.00 | 5,575 USD | |
2022-10-04 | 2022-10-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
137
-0.4%
25.003,425 USD |
137 -0.4% | 25.00 | 3,425 USD | |
2022-10-04 | 2022-10-03 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
13
-0.0%
25.00325 USD |
13 -0.0% | 25.00 | 325 USD | |
2022-10-04 | 2022-10-03 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
167
-0.5%
25.004,175 USD |
167 -0.5% | 25.00 | 4,175 USD | |
2022-10-04 | 2022-09-30 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
647
-2.0%
25.0716,221 USD |
647 -2.0% | 25.07 | 16,221 USD | |
2022-10-04 | 2022-09-30 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
2,914
-8.3%
25.0773,056 USD |
2,914 -8.3% | 25.07 | 73,056 USD |